octaplas

BIOLOGICAL3 trials

Sponsors

Octapharma, University College, London

Conditions

COVID19Cardiac SurgeryCoagulopathyLiver DysfunctionLiver SurgeryThrombotic Thrombocytopenic Purpura

Phase 2

Study of Plasma Exchange in Severe COVID-19

CompletedNCT04623255

University College, LondonCOVID19

Start: 2020-10-16End: 2022-01-31Updated: 2024-06-07

Phase 4

Octaplas Pediatric Plasma Replacement Trial

CompletedNCT02050841

OctapharmaCardiac Surgery, Coagulopathy, Liver Dysfunction +1

Start: 2014-12-31End: 2017-12-04Updated: 2020-06-23

Unknown Phase

Octaplas Adult TTP Trial

TerminatedNCT01938404

OctapharmaThrombotic Thrombocytopenic Purpura

Start: 2017-06-06End: 2017-08-02Updated: 2019-10-14

Related Papers

A randomised controlled trial of plasma exchange compared to standard of care in the treatment of severe COVID-19 infection (COVIPLEX).

2024-07-233 citations

Solvent/Detergent-Treated Plasma in the Management of Pediatric Patients Who Require Replacement of Multiple Coagulation Factors: An Open-Label, Multicenter, Post-marketing Study

Frontiers in Pediatrics2020-09-1714 citations